FDA Warning Letter — BP

Case 638760 — FEI 3011724757

The FDA took a Warning Letter action against BP on Aug 2, 2022 (New Brunswick, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
BP
Date
Aug 2, 2022
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
New Brunswick, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.